Literature DB >> 21699631

Effect of a low concentration of a cationic steroid antibiotic (CSA-13) on the formation of a biofilm by Pseudomonas aeruginosa.

C Nagant1, Y Feng, B Lucas, K Braeckmans, P Savage, J P Dehaye.   

Abstract

AIMS: Cationic steroids like CSA-13 have been designed by analogy with antimicrobial cationic peptides and have bactericidal properties. The purpose of this work was to evaluate the effect of a low concentration (1 mg l(-1)) of CSA-13 on the formation of a biofilm by eight strains of Pseudomonas aeruginosa (four mucoid and four nonmucoid strains) on an inert surface. METHOD AND
RESULTS: The biofilm formation was measured with the Crystal Violet method. CSA-13 inhibited the formation of a biofilm by three strains. The zeta potential varied among the strains. The inhibition by the cationic steroid analogue affected the populations of bacteria with the lowest zeta potential. P. aeruginosa bound a fluorescent, more hydrophobic analogue of CSA-13 but there was no correlation between this binding and the inhibition by CSA-13 of biofilm formation. The interaction of CSA-13 with bacteria did not modify their ability to produce rhamnolipids.
CONCLUSIONS: A low concentration of CSA-13 inhibits the formation of a biofilm by P. aeruginosa through electrostatic interactions and without affecting the production of rhamnolipids. SIGNIFICANCE AND IMPACT OF THE STUDY: A low, nontoxic concentration of CSA-13 might be beneficial for the prevention of biofilm formation.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21699631     DOI: 10.1111/j.1365-2672.2011.05085.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  7 in total

1.  Bactericidal Activity of Ceragenin CSA-13 in Cell Culture and in an Animal Model of Peritoneal Infection.

Authors:  Robert Bucki; Katarzyna Niemirowicz; Urszula Wnorowska; Fitzroy J Byfield; Ewelina Piktel; Marzena Wątek; Paul A Janmey; Paul B Savage
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

2.  Antibacterial and Antibiofilm Activities of Ceragenins against Pseudomonas aeruginosa Clinical Isolates.

Authors:  Çağla Bozkurt Güzel; Mayram Hacioğlu; Gözde Inci; Paul B Savage
Journal:  Turk J Pharm Sci       Date:  2019-11-11

3.  Study of the effect of antimicrobial peptide mimic, CSA-13, on an established biofilm formed by Pseudomonas aeruginosa.

Authors:  Carole Nagant; Betsey Pitts; Philip S Stewart; Yanshu Feng; Paul B Savage; Jean-Paul Dehaye
Journal:  Microbiologyopen       Date:  2013-02-25       Impact factor: 3.139

4.  Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.

Authors:  Katarzyna Niemirowicz; Urszula Surel; Agnieszka Z Wilczewska; Joanna Mystkowska; Ewelina Piktel; Xiaobo Gu; Zbigniew Namiot; Alina Kułakowska; Paul B Savage; Robert Bucki
Journal:  J Nanobiotechnology       Date:  2015-05-01       Impact factor: 10.435

5.  Bacterial cell surface heterogeneity: a pathogen's disguise.

Authors:  Henny C van der Mei; Henk J Busscher
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

6.  An Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity.

Authors:  Luigi Mandrich; Mariangela Cerreta; Giuseppe Manco
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

Review 7.  Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications.

Authors:  Urszula Wnorowska; Krzysztof Fiedoruk; Ewelina Piktel; Suhanya V Prasad; Magdalena Sulik; Marianna Janion; Tamara Daniluk; Paul B Savage; Robert Bucki
Journal:  J Nanobiotechnology       Date:  2020-01-02       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.